{
    "title": "A systematic review of systematic reviews and pooled meta-analysis on pharmacological interventions to improve cancer-related fatigue.",
    "doc_id": "34051301",
    "writer": "Belloni S",
    "year": "2021",
    "summary": "",
    "abstract": "Background:\n        \n      \n      Evidence regarding the pharmacological interventions to manage cancer-related fatigue (CRF) is currently synthesized in several systematic reviews, portraying a fragmented literature synthesis. Thus, we aimed to critically appraise the available systematic reviews on pharmacological intervention for improving CRF in adult cancer patients.\n    \n\n\n          Methods:\n        \n      \n      Three databases were systematically searched from January 2010 to July 2020. The pooled meta-analyses' effect sizes (standardized mean difference, SMD) were quantitatively pooled using a random-effects model. Chi-squared (Q) and I-square statistics (IÂ²) tested the heterogeneity.\n    \n\n\n          Results:\n        \n      \n      The SMD of the effect of psychostimulants on CRF was -0.20 (95 % CI: -0.32, 0.08; p < 0.0001), along with significant higher improvement of fatigue (SMD=-0.69; 95 % CI=-1.29, -0,09, p < 0.0001) after methylphenidate administration. No statistical differences were found in the occurrences of adverse events between methylphenidate and placebo.\n    \n\n\n          Conclusions:\n        \n      \n      This study corroborated that psychostimulant therapy may be moderately effective in reducing CRF. Scarce evidence on the short- and long-term adverse events.\n    \n\n\n          Prospero:\n        \n      \n      CRD42020181879 (registration date: 26/07/2020).",
    "link": "https://pubmed.ncbi.nlm.nih.gov/34051301/"
}